These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1985 related items for PubMed ID: 19843493

  • 1. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [Abstract] [Full Text] [Related]

  • 2. Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
    Gellatly RM, Ackman ML.
    Ann Pharmacother; 2008 Jun; 42(6):836-40. PubMed ID: 18413689
    [Abstract] [Full Text] [Related]

  • 3. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
    Luinstra M, Naunton M, Peterson GM, Bereznicki L.
    J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
    [Abstract] [Full Text] [Related]

  • 4. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.
    Rahme E, Barkun A, Nedjar H, Gaugris S, Watson D.
    Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130
    [Abstract] [Full Text] [Related]

  • 5. Management of patients with high gastrointestinal risk on antiplatelet therapy.
    Cryer B.
    Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention.
    Saini SD, Schoenfeld P, Fendrick AM, Scheiman J.
    Arch Intern Med; 2008 Aug 11; 168(15):1684-90; discussion 1691. PubMed ID: 18695083
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI.
    J Gastroenterol Hepatol; 2012 Apr 11; 27(4):654-61. PubMed ID: 22283743
    [Abstract] [Full Text] [Related]

  • 11. Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulations.
    Logman JF, Heeg BM, Herlitz J, van Hout BA.
    Appl Health Econ Health Policy; 2010 Apr 11; 8(4):251-65. PubMed ID: 20578780
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
    Ortolani P, Marino M, Marzocchi A, De Palma R, Branzi A.
    J Cardiovasc Med (Hagerstown); 2012 Dec 11; 13(12):783-9. PubMed ID: 21252697
    [Abstract] [Full Text] [Related]

  • 14. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K.
    Thromb Haemost; 2010 Dec 11; 104(6):1211-8. PubMed ID: 20941464
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed.
    Schreiner GC, Laine L, Murphy SA, Cannon CP.
    Crit Pathw Cardiol; 2007 Dec 11; 6(4):169-72. PubMed ID: 18091407
    [Abstract] [Full Text] [Related]

  • 16. Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors.
    Sarafoff N, Sibbing D, Sonntag U, Ellert J, Schulz S, Byrne RA, Mehilli J, Schömig A, Kastrati A.
    Thromb Haemost; 2010 Sep 11; 104(3):626-32. PubMed ID: 20664905
    [Abstract] [Full Text] [Related]

  • 17. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
    Ng FH, Wong SY, Lam KF, Chang CM, Lau YK, Chu WM, Wong BC.
    Am J Gastroenterol; 2008 Apr 11; 103(4):865-71. PubMed ID: 18177451
    [Abstract] [Full Text] [Related]

  • 18. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.
    Pharmacotherapy; 2007 May 11; 27(5):691-6. PubMed ID: 17461704
    [Abstract] [Full Text] [Related]

  • 19. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
    Shrestha K, Hughes JD, Lee YP, Parsons R.
    Qual Prim Care; 2011 May 11; 19(1):35-42. PubMed ID: 21703110
    [Abstract] [Full Text] [Related]

  • 20. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
    Aihara H, Sato A, Takeyasu N, Nishina H, Hoshi T, Akiyama D, Kakefuda Y, Watabe H, Aonuma K, ICAS Registry Investigators.
    Catheter Cardiovasc Interv; 2012 Oct 01; 80(4):556-63. PubMed ID: 22234956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 100.